Closed consultation: Classification of topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media
Current status: Closed
This consultation ran from August 14, 2025 to October 28, 2025.
The purpose of this consultation was to seek input on Health Canada's intended approach to the classification and regulation of topical products at the cosmetic-drug interface that contain:
- human-derived exosomes
- human extracellular vesicles and/or
- human cell-conditioned media
Who was the focus of this consultation
We engaged with:
- manufacturers and distributors of topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media
- industry and academics conducting research on topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media
- health care practitioners
- interested members of the public
Key questions for discussion
Your comments and inputs were sought on the proposed approach to the classification and regulation of topical products that contain:
- human-derived exosomes
- human extracellular vesicles and/or
- human cell-conditioned media
Related information
Contact us
Therapeutic Products Classification Committee Secretariat
Drug-Device.Classification.Drogue-Instrument@hc-sc.gc.ca